Roivant Sciences Insider Sold Shares Worth $5,918,000, According to a Recent SEC Filing
23 april, 09:42
23 april, 09:42
03:42 AM EDT, 04/23/2026 (MT Newswires) -- Eric Venker, President &Immunovant Chief Executive Officer, on April 20, 2026, sold 200,000 shares in Roivant Sciences (ROIV) for $5,918,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1635088/000163508826000044/xslF345X05/wk-form4_1776896865.xml
23 april, 09:42
03:42 AM EDT, 04/23/2026 (MT Newswires) -- Eric Venker, President &Immunovant Chief Executive Officer, on April 20, 2026, sold 200,000 shares in Roivant Sciences (ROIV) for $5,918,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1635088/000163508826000044/xslF345X05/wk-form4_1776896865.xml
Analys
Rapporter

Analys
Rapporter

1 DAG %
Senast

OMX Stockholm 30
0,66%
(vid stängning)
fonder
30 april, 15:25
Teknikfonder rusade i april – hälsovård tappade mest
Vitec Software Group
30 april, 15:00
Vitec: Vågar man tro på en vändning?
OMX Stockholm 30
1 DAG %
Senast
3 060,48